DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results

Montrouge, France, July 31, 2023 DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results ...

Related Keywords

France ,United States ,Montrouge ,France General ,French ,American ,Angela Marcucci ,Katie Matthews ,Company Adss ,European Union ,International Financial Reporting Standards ,Exchange Commission ,Health Science ,Drug Administration ,Research Development ,Receives Feedback ,Design Elements ,Nasdaq Stock Market ,Written Responses ,Optimal Management ,Allergy Relief ,Biologics License Applications ,Typec Meeting Written Responses ,Daniel Tass ,Chief Executive Officer ,Viaskin Peanut ,New England Journal ,Second Quarter ,Six Months Ended June ,American Depositary Shares ,Net Loss Per ,North American ,Basking Ridge ,Euronext Paris ,Nasdaq Global Select Market ,French Autorit ,Des March ,Markets ,